You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Mobile-Delivered Personalized Feedback Intervention for Black Individuals who Engage in Hazardous Drinking

    SBC: HEALTH BEHAVIOR SOLUTIONS INC            Topic: 400

    PROJECT SUMMARY/ABSTRACT Black persons are the second largest racial minority group in the United States (US) and experience striking health disparities, particularly in terms of hazardous drinking and co-occurring elevated anxiety. The co- occurrence of these risk factors contributes to worse physical/mental health outcomes among Black individuals. Few interventions to date have targeted hazardou ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Ambulatory cryocooling therapy device

    SBC: NANOHMICS INC            Topic: NIAMS

    PI: Savoy Project Summary Tissue protection following injury begins with shutting down vasodilation and limiting subsequent swelling through the application of cold. In many cases, the cold comes in the form of bags of ice or frozen cold packs, or commercial cooling products such ice packs or ice pack holding limb wraps. In others it may be via a chilled water circulator device, for example the Po ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Finding undiagnosed ATTR-CM patients using AI technology in clinical settings

    SBC: ATOMO INC            Topic: NHLBI

    Project Summary: Transthyretin Amyloidosis with cardiac myopathy, ATTR-CM, represent a serious healthcare issue. ATTR-CM is involved in 13% of heart failure, 16% of transcatheter aortic-valve replacement, and 5% of individuals with presumed hypertrophic cardiomyopathy. The primary challenge is that most patients are undiagnosed or their diagnosis is delayed for multiple years. Since the damage ATT ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Pharmacological Treatment for Preeclampsia

    SBC: ARTEMIS BIOTECHNOLOGIES LLC            Topic: NICHD

    Novel Pharmacological Treatment for Preeclampsia AbstractPreeclampsia (preE) is a serious hypertensive complication of pregnancy often accompanied by proteinuria and edema, sometimes with encephalopathy, seizures, and hepatic failure. PreE complicates 5 to 10% of pregnancies and is a major cause of maternal and fetal morbidity and mortality worldwide. Nevertheless, an effective therapy for this di ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection

    SBC: BASE PAIR BIOTECHNOLOGIES INC            Topic: NIBIB

    Project Summary/Abstract The United States is experiencing an epidemic of unprecedented scope with heroin use resurging and a troubling pervasive increase in abuse of prescription opioids such as fentanyl, fentanyl derivatives, methadone, oxycodone and hydrocodone. More than 6 out of 10 drug overdoses are now opioid-related, resulting in ~90 deaths/day and a more than $75B/year economic impact. Ad ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Medical Device Identifier to Improve Emergency Triage

    SBC: BRIDGESOURCE MEDICAL, CORP.            Topic: R

    Project Summary Abstract Cardiovascular Implantable Electronic Devices (CIEDs) like a Permanent Pacemaker or Implantable Defibrillator are implanted in over 3 million Americans, with the average age of implantation in the 60s, 40% ≥ 70 years old, and 28% ≥ 80 years old. When a patient presents to the Emergency Department (ED) with an unknown CIED, reprogramming of the device is often necessary ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG

    SBC: CLEARNANO INC            Topic: 102

    AbstractPartial nephrectomy is becoming an increasingly important treatment for kidney cancer because more than 60% of kidney cancer cases are diagnosed in early, localized stages. Compared to radical nephrectomy, partial nephrectomy offers much better preservation of renal function while having an equivalent oncological efficacy for the localized kidney cancer, thereby significantly reducing the ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Development and Production of Standardized Reference Diets for Zebrafish Research

    SBC: Meridian Biotech, LLC            Topic: OD

    Project Summary The over-arching goal of this Phase II SBIR proposal is to optimize and implement high quality standard reference diets for the Zebrafish (Danio rerio), an animal model of critical importance to the understanding of human health and development of vertebrate organisms. A key problem in the industry is that high quality standardized reference diets, with appropriate physical propert ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Convenient rapid and portable tool for the detection of ribonucleases

    SBC: ATTOGENE CORPORATION            Topic: 400

    Summary/AbstractThe past decade has brought an escalating growth of important new commercial applications for RNA. RNA molecules have emerged as the preeminent regulators of gene expression. They have a unique ability to edit genomes and destabilize gene products. New diagnostic applications for RNA are continually being discovered. Last but not least, modified mRNA nanoparticle formulations are e ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Privacy-Preserving Connectivity for Rare-Disease Patients

    SBC: GENEIAL LLC            Topic: 172

    Abstract / Summary Safeguarding privacy of data assets – while simultaneously facilitating data sharing and exchange – is paramount to sustaining the value creation of genomics for precision medicine and population health. One of the most significant challenges for Xia-Gibbs Syndrome (XGS) research and rare disease studies in general is the lack of integrated, privacy-preserving platforms to f ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government